Copyright Reports & Markets. All rights reserved.

Global Wound Biologics Market Research Report 2021

Request for Sample of this report
Buy now

1 Wound Biologics Market Overview

  • 1.1 Product Overview and Scope of Wound Biologics
  • 1.2 Wound Biologics Segment by Type
    • 1.2.1 Global Wound Biologics Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Biological Skin Substitutes
    • 1.2.3 Enzyme Preparation
    • 1.2.4 Growth Factor
  • 1.3 Wound Biologics Segment by Application
    • 1.3.1 Wound Biologics Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Drugstore
    • 1.3.4 Others
  • 1.4 Global Wound Biologics Market Size Estimates and Forecasts
    • 1.4.1 Global Wound Biologics Revenue 2016-2027
    • 1.4.2 Global Wound Biologics Sales 2016-2027
    • 1.4.3 Wound Biologics Market Size by Region: 2016 Versus 2021 Versus 2027

2 Wound Biologics Market Competition by Manufacturers

  • 2.1 Global Wound Biologics Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Wound Biologics Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Wound Biologics Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Wound Biologics Manufacturing Sites, Area Served, Product Type
  • 2.5 Wound Biologics Market Competitive Situation and Trends
    • 2.5.1 Wound Biologics Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Wound Biologics Players Market Share by Revenue
    • 2.5.3 Global Wound Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Wound Biologics Retrospective Market Scenario by Region

  • 3.1 Global Wound Biologics Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Wound Biologics Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Wound Biologics Market Facts & Figures by Country
    • 3.3.1 North America Wound Biologics Sales by Country
    • 3.3.2 North America Wound Biologics Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Wound Biologics Market Facts & Figures by Country
    • 3.4.1 Europe Wound Biologics Sales by Country
    • 3.4.2 Europe Wound Biologics Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Wound Biologics Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Wound Biologics Sales by Region
    • 3.5.2 Asia Pacific Wound Biologics Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Wound Biologics Market Facts & Figures by Country
    • 3.6.1 Latin America Wound Biologics Sales by Country
    • 3.6.2 Latin America Wound Biologics Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Wound Biologics Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Wound Biologics Sales by Country
    • 3.7.2 Middle East and Africa Wound Biologics Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Wound Biologics Historic Market Analysis by Type

  • 4.1 Global Wound Biologics Sales Market Share by Type (2016-2021)
  • 4.2 Global Wound Biologics Revenue Market Share by Type (2016-2021)
  • 4.3 Global Wound Biologics Price by Type (2016-2021)

5 Global Wound Biologics Historic Market Analysis by Application

  • 5.1 Global Wound Biologics Sales Market Share by Application (2016-2021)
  • 5.2 Global Wound Biologics Revenue Market Share by Application (2016-2021)
  • 5.3 Global Wound Biologics Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Avita Medical
    • 6.1.1 Avita Medical Corporation Information
    • 6.1.2 Avita Medical Description and Business Overview
    • 6.1.3 Avita Medical Wound Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Avita Medical Product Portfolio
    • 6.1.5 Avita Medical Recent Developments/Updates
  • 6.2 ConvaTec
    • 6.2.1 ConvaTec Corporation Information
    • 6.2.2 ConvaTec Description and Business Overview
    • 6.2.3 ConvaTec Wound Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 ConvaTec Product Portfolio
    • 6.2.5 ConvaTec Recent Developments/Updates
  • 6.3 Acelity
    • 6.3.1 Acelity Corporation Information
    • 6.3.2 Acelity Description and Business Overview
    • 6.3.3 Acelity Wound Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Acelity Product Portfolio
    • 6.3.5 Acelity Recent Developments/Updates
  • 6.4 Cytori Therapeutic
    • 6.4.1 Cytori Therapeutic Corporation Information
    • 6.4.2 Cytori Therapeutic Description and Business Overview
    • 6.4.3 Cytori Therapeutic Wound Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Cytori Therapeutic Product Portfolio
    • 6.4.5 Cytori Therapeutic Recent Developments/Updates
  • 6.5 MacroCure
    • 6.5.1 MacroCure Corporation Information
    • 6.5.2 MacroCure Description and Business Overview
    • 6.5.3 MacroCure Wound Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 MacroCure Product Portfolio
    • 6.5.5 MacroCure Recent Developments/Updates
  • 6.6 Nuo Therapeutics
    • 6.6.1 Nuo Therapeutics Corporation Information
    • 6.6.2 Nuo Therapeutics Description and Business Overview
    • 6.6.3 Nuo Therapeutics Wound Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Nuo Therapeutics Product Portfolio
    • 6.6.5 Nuo Therapeutics Recent Developments/Updates
  • 6.7 Molyncke Health Care
    • 6.6.1 Molyncke Health Care Corporation Information
    • 6.6.2 Molyncke Health Care Description and Business Overview
    • 6.6.3 Molyncke Health Care Wound Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Molyncke Health Care Product Portfolio
    • 6.7.5 Molyncke Health Care Recent Developments/Updates
  • 6.8 Osiris Therapeutics
    • 6.8.1 Osiris Therapeutics Corporation Information
    • 6.8.2 Osiris Therapeutics Description and Business Overview
    • 6.8.3 Osiris Therapeutics Wound Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Osiris Therapeutics Product Portfolio
    • 6.8.5 Osiris Therapeutics Recent Developments/Updates
  • 6.9 Smith And Nephew
    • 6.9.1 Smith And Nephew Corporation Information
    • 6.9.2 Smith And Nephew Description and Business Overview
    • 6.9.3 Smith And Nephew Wound Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Smith And Nephew Product Portfolio
    • 6.9.5 Smith And Nephew Recent Developments/Updates
  • 6.10 Organogenesis
    • 6.10.1 Organogenesis Corporation Information
    • 6.10.2 Organogenesis Description and Business Overview
    • 6.10.3 Organogenesis Wound Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Organogenesis Product Portfolio
    • 6.10.5 Organogenesis Recent Developments/Updates

7 Wound Biologics Manufacturing Cost Analysis

  • 7.1 Wound Biologics Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Wound Biologics
  • 7.4 Wound Biologics Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Wound Biologics Distributors List
  • 8.3 Wound Biologics Customers

9 Wound Biologics Market Dynamics

  • 9.1 Wound Biologics Industry Trends
  • 9.2 Wound Biologics Growth Drivers
  • 9.3 Wound Biologics Market Challenges
  • 9.4 Wound Biologics Market Restraints

10 Global Market Forecast

  • 10.1 Wound Biologics Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Wound Biologics by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Wound Biologics by Type (2022-2027)
  • 10.2 Wound Biologics Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Wound Biologics by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Wound Biologics by Application (2022-2027)
  • 10.3 Wound Biologics Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Wound Biologics by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Wound Biologics by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Biological Skin Substitutes
    Enzyme Preparation
    Growth Factor

    Segment by Application
    Hospital
    Drugstore
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    By Company
    Avita Medical
    ConvaTec
    Acelity
    Cytori Therapeutic
    MacroCure
    Nuo Therapeutics
    Molyncke Health Care
    Osiris Therapeutics
    Smith And Nephew
    Organogenesis

    Buy now